NewAmsterdam Pharma Company N.V. NAMS
19.51 USD -0.23 (-1.17%)
Regular-session close
18.90 -0.61 -3.12%
After hours · Nov 19, 5:01 PM ET
19.30 Day range 20.36
17.90 52-week range 42.21
- YTD
- -44.38%
- 1 year
- -49.48%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 22.50M | 45.56M | 14.09M | 102.69M | 0 | |
| 22.50M | 45.56M | 14.09M | 102.69M | 0 | |
| -225.68M | -176.29M | -182.97M | -3.56M | -29.84M | |
| -203.82M | -241.60M | -176.94M | -22.63M | -28.60M | |
| -1.72 | -2.56 | -2.15 | -1.19 | -1.21 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 491.32M | 771.74M | 340.45M | 438.52M | 53.09M | |
| 769.28M | 864.62M | 347.10M | 531.58M | 59.78M | |
| 85.85M | 107.12M | 58.70M | 47.06M | 9.99M | |
| 202.00K | 448.00K | 60.00K | 118.00K | 164.00K | |
| 683.43M | 757.50M | 288.39M | 484.52M | 49.79M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -147.78M | -158.56M | -141.22M | 10.66M | -25.16M | |
| -174.92M | -62.85M | -24.00K | -221.00K | -20.00K | |
| 29.52M | 659.51M | 8.91M | 391.90M | 68.99M | |
| -246.00K | -672.00K | -24.00K | -221.00K | -20.00K | |
| -293.18M | 438.10M | -132.33M | 402.35M | 43.81M |
